Somewhat Positive Press Coverage Somewhat Unlikely to Affect American Vanguard (AVD) Share Price
News stories about American Vanguard (NYSE:AVD) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. American Vanguard earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave news articles about the basic materials company an impact score of 45.4529185801866 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
American Vanguard stock traded up $0.10 on Tuesday, hitting $22.85. 11,471 shares of the stock traded hands, compared to its average volume of 114,365. The company has a current ratio of 2.02, a quick ratio of 1.04 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $658.46, a P/E ratio of 40.09 and a beta of 1.19. American Vanguard has a 1 year low of $15.20 and a 1 year high of $24.00.
American Vanguard (NYSE:AVD) last announced its quarterly earnings data on Monday, March 12th. The basic materials company reported $0.17 EPS for the quarter, meeting the consensus estimate of $0.17. The business had revenue of $116.50 million during the quarter, compared to analyst estimates of $110.06 million. American Vanguard had a return on equity of 5.74% and a net margin of 5.70%. The company’s revenue for the quarter was up 33.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.13 earnings per share. analysts predict that American Vanguard will post 0.8 earnings per share for the current year.
Several equities analysts have commented on the company. Zacks Investment Research raised American Vanguard from a “sell” rating to a “hold” rating in a research report on Tuesday, January 2nd. Roth Capital reissued a “buy” rating on shares of American Vanguard in a research report on Thursday, March 15th. Finally, ValuEngine raised American Vanguard from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company. American Vanguard currently has a consensus rating of “Hold” and an average target price of $25.33.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.